{"ticker": {"uuid": "b557893f-9366-4593-99f8-75f6547bb343", "symbol": "4523", "name": "Eisai Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "How Investors May Respond To Eisai (TSE:4523) Advancing Lecanemab Data And New CNS Oncology Filings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T17:02:18+00:00", "published_display": "12 Jul 2026 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co Ltd (4523)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPNHBjQjcyZDFRWnd5UlNhY0FNdFJuMjRFN1RoTXVreVBsSXVlVnEwaFEzZ1piS0Z6WFJEbGpVQjVMRExRX0s2a0swbEEydm9XZkxFSzg5X0FZLW9vUEYzcmpUU2VFRGx0ZC1aR2F5VVBrN2lHb21Ua2dVcHVYSEJaT2JJNV9yZndaOTRQblBfVUdkXzNqX2c?oc=5", "source_name": "MSN", "published_at": "2026-07-11T12:20:23+00:00", "published_display": "11 Jul 2026 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Could Be 15% Below Fair Value As Pipeline News Builds", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai outlines its long-term growth strategy as a global pharma player", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPV1c2NHNBQzBMQkUtZkh4QW44cHRKR3lZVmFESmpncWVzYUlmZ0xDVVlyMEZwNm52OXRIVXRqWXpxNnVhVEhkS01nbkdXOWctdktGSHZGRlNLZ0dkZ0Q3N055ejVJTW1KWHItYWFyY1BuNTRWZTdLV2k1ejBwREJmazZ3UUQzVUd2bDVjTWRMRDE4SlI5NmdYc2p1cUpHWVJtYTZvQWpBVXN0Z2NVOF8wNnJrbFlYZnU1VVVPTU1rMmpyanFsUXV0dw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T16:05:32+00:00", "published_display": "04 Jul 2026 16:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co., Ltd.'s Acceptance of Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant for Evaluation by the United Kingdom?s Medicines and Healthcare Products Regulatory Agency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPYVlMOGc0UEFSUGRhNXNsX21VempGcDZ6czM4ZVIwUTcxdTNxOHYwQ0hhMHVzaUw1Y3l5SGhIQ3NmS1NsczdFR3d6b2poTVhsVmxQZ2NwU19ERHJNdVNxaEtUTE52a0ZXV1VOVll2UGhQOTBiSVYyU1piemt2Qk1sT1Y5cXlGOElRVVVKb0JRTFFSUE1hbG96M2RnZ3duZVFHZ21Ja2xvTEJfSUJIUWo4cmtIdW1SWTRMbW1mWjFRbUZwdlAwYVctUFpTZEVWZlk0UVpLTGlJUU4xX29DNVcxQm52RQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T22:00:00+00:00", "published_display": "01 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co., Ltd. (ESAIY) Analyst/Investor Day - Slideshow (OTCMKTS:ESAIY) 2026-05-25", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxONHBoWlNKQlNId3pjc215WTRILU1RcGwyYjg1UDM3QndKZzZWUHFubVdFVjhBVFJsSzNXX2o0RXhZemVhbE5RR3htbnRVRTA3dW9IdjRiRnB4N1BPb3RyZlRSOGpmczVVaEFEcUp6WkJ3b3U2cDY4MFhkSUJjYzNCN2NqRXVCZ2FENnV1T0NFQXllSjFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Valuation Check After Recent Share Price Pullback And LEQEMBI Growth Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxONkRvUkJOUnlVR0dPYzV5UTFIbmN4aEVyazZialFveXRjTTdlVTdVM1ZjRlpCMzZnaFVaVnRpRlNXeUQ1bjdlamd0bXRyajYyUW9XM3ptS2tmR0tqOHFyYUZNUmJJeUVwaDhBb0pwdGQwc1BsSk81OXhNQlpsZk5GdlhKYmNJWUd3amdrWnNMYkZZUUpWOEtBOWdIYw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Valuation Check As Recent Momentum Meets Mixed Long Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOVUxJVkdNWk9tOHpXSjh5QjMyOS1PYkpYTFNpRDBVRGpUYWRUbmM2UXBBMEZvd0V6UW9fT1ViR0FsZ01PbG5PWFhQNExrMUFtUzFMRmVPb1RaRzNhSG4xVVNfMTlJX1dDWkFMbVNidFBYMWM4S04tSU1OZ3ZHaHhxbURXZDN4NWRWZ2FKSEcxMDZaTWVZYUZYWWw1OA?oc=5", "source_name": "Market source", "published_at": "2026-04-05T07:00:00+00:00", "published_display": "05 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Eisai (TSE:4523) Valuation After Mixed Share Price Momentum And LEQEMBI Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPa2RnMHJMMWZoZGhYaEttM0pCbVl6QUJ6VVFuT1dsUVhaMkh3SFdBMFEyRl8ybmMxWGNzcEk5OV9tN29QS214cDFXRkhjMnNHczRZeTROazN6cG91QkloNEFfM0dJTFV6S0RQOGxrbERtTGUweU0zMlFDbFBsWEJBb0ZtaUdMMWs?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai strikes Japan licensing deal with Shanghai Henlius Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTjMxVFhfOU56V1pzOFFxWWd2eWIzMTNTS1BUd1A3NFJjVGpqR0dFX2JEdTJpX1BwcnNicXdlLWVPM1BRbmVRcU5TSzN5Uy1QNDRqbUw0QXRGXzIyMU9qSmFjNU5CNzB4ZzNhRHdFb3RkS2RmRDlpanM3VzFsUDRQeW52NVJwWlVQcWhELXV1OV9hdjNsX1VqbVEydmNwVjJ5N0w4MTNpNS1pUlZvNVpEU0V5blZsbkZraFFpWVpYQURXZHFXNnZ4dGU3QVZuS2dqRWc?oc=5", "source_name": "Reuters", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Submits New Drug Application for Subcutaneous Formulation of \u201cLEQEMBI\u00ae\u201d for the Treatment of Early Alzheimer\u2019s Disease in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQRm5BcDdYVkhlN2ZycmMwdjBuVmJfb19ma3FLY2VFNnZ5dHo5Z1dJYzU2UkE5WTlwQzA2dzJLMnhzUDhoejZoNHNMQ2hCdHg3anB3dGlIVEdtcjRsQ2Y3X1M1Wi1HV29KVmJJZTJ6YlFkN1lwUlNSdzVoZ2FtZkRkTWV2RW1qY0E2c2doRHBJSGRTY1JockstYWRkVEpOa3RsZ0hpMEFpODdmc21hOEhXalBnMzZuQXlxQWFIaTlWNzI?oc=5", "source_name": "Biogen", "published_at": "2025-11-27T08:00:00+00:00", "published_display": "27 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Eisai Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIZ3pxT1hjUXJHU0lWTDJNVEM2YktqYWpLNm1OdC1WVUYtNGhQZW5OVTRyYjJ4THZVQ1NnRnpLaXBTb1dfeGlVdnN4cmJXSzdlazkyQTJDOTRKdG9Fb3lR?oc=5", "source_name": "TradingView", "published_at": "2025-09-25T03:10:06+00:00", "published_display": "25 Sep 2025 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai to Launch \u201cPariet\u00ae S,\u201d the First Proton Pump Inhibitor RX-to-OTC in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1jX1VSZlpuUzA1T25EeFJ1bzBFQWNyUTRmcHVrOXl5NGRNVzYxMjZaYkZlcERHcVNHS1R2ejRXbE95V2VDdWRDdWlEZXZyZm9MTXFnUGpMTXl0dXc?oc=5", "source_name": "Eisai", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "To Develop Japan\u2019s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research | News ReleaseNews Release\uff1a2022", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9ib2QtUlRnNEdXN1JvZnhkczhGQW9ZWnZ1WW9QODlYbnJsaVhTaGpjQnQ1UmFwaDl2d1VaaVZCSGJ4VlpwVmJGQWoyRUhVdlF4cW1BcG5VVF9JMTg?oc=5", "source_name": "Eisai", "published_at": "2022-11-22T08:00:00+00:00", "published_display": "22 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Eisai amend collaboration agreements on Alzheimer\u2019s disease treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNjhMczY5QzJjUm40c2M4aGJKRXdJbmJ5MXJPSGgtYUhpVjJvcWNwWWhQTFlmZ240ZUdUdHNIaERaSjJFNG05UmJueGVsXzhYOHNWSTZLNmhDd2dOdEdGUFd5czRwUlo3dngyaUYyM0NsMlE3ZEFndnhCbWw2dGhyaE9FR2dySXhoZmVPLThEOGhjUF9ub3laU0xtRDRZMC16VHRVUDRLODExVTFRa2Z4QWtvR0N4NktGZl8xZ1o5Yw?oc=5", "source_name": "Biogen", "published_at": "2022-03-14T07:00:00+00:00", "published_display": "14 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EISAI COMPLETES CONSTRUCTION OF THE 5TH MANUFACTURING BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN | News ReleaseNews Release\uff1a2020", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBvUk5yUEd6a3RlZk9JRFlaeHY1aVJOeW94Qy1OUW5OU0hteTJhczFYRlFRbDRjdzVTOWhkcTZkM2RRZjFqMUY4X3J2NldhUVBnclBLQzJoODNRNVE?oc=5", "source_name": "Eisai", "published_at": "2020-12-18T08:00:00+00:00", "published_display": "18 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai co-establishes \u201cGlobal Health Innovative Technology Fund,\u201d Japan's first public\u2013private partnership to eliminate infectious disease in developing countries | Patients and People", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE96R0NfVkE2aXhYRl9SRXREU2M3YU9OVVlYNndNM0xGaXZnMWtROHdUcFB3WU9wdUlBZnBzWjhkWmIzRl94eWFvR1RhbElvYkVCTU9ZMWxVYUJDVTNvOXUtZg?oc=5", "source_name": "Eisai", "published_at": "2013-07-11T07:00:00+00:00", "published_display": "11 Jul 2013 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How Investors May Respond To Eisai (TSE:4523) Advancing Lecanemab Data And New CNS Oncology Filings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-12T17:02:18+00:00", "published_display": "12 Jul 2026 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co Ltd (4523)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPNHBjQjcyZDFRWnd5UlNhY0FNdFJuMjRFN1RoTXVreVBsSXVlVnEwaFEzZ1piS0Z6WFJEbGpVQjVMRExRX0s2a0swbEEydm9XZkxFSzg5X0FZLW9vUEYzcmpUU2VFRGx0ZC1aR2F5VVBrN2lHb21Ua2dVcHVYSEJaT2JJNV9yZndaOTRQblBfVUdkXzNqX2c?oc=5", "source_name": "MSN", "published_at": "2026-07-11T12:20:23+00:00", "published_display": "11 Jul 2026 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Could Be 15% Below Fair Value As Pipeline News Builds", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai outlines its long-term growth strategy as a global pharma player", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPV1c2NHNBQzBMQkUtZkh4QW44cHRKR3lZVmFESmpncWVzYUlmZ0xDVVlyMEZwNm52OXRIVXRqWXpxNnVhVEhkS01nbkdXOWctdktGSHZGRlNLZ0dkZ0Q3N055ejVJTW1KWHItYWFyY1BuNTRWZTdLV2k1ejBwREJmazZ3UUQzVUd2bDVjTWRMRDE4SlI5NmdYc2p1cUpHWVJtYTZvQWpBVXN0Z2NVOF8wNnJrbFlYZnU1VVVPTU1rMmpyanFsUXV0dw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T16:05:32+00:00", "published_display": "04 Jul 2026 16:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co., Ltd.'s Acceptance of Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant for Evaluation by the United Kingdom?s Medicines and Healthcare Products Regulatory Agency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPYVlMOGc0UEFSUGRhNXNsX21VempGcDZ6czM4ZVIwUTcxdTNxOHYwQ0hhMHVzaUw1Y3l5SGhIQ3NmS1NsczdFR3d6b2poTVhsVmxQZ2NwU19ERHJNdVNxaEtUTE52a0ZXV1VOVll2UGhQOTBiSVYyU1piemt2Qk1sT1Y5cXlGOElRVVVKb0JRTFFSUE1hbG96M2RnZ3duZVFHZ21Ja2xvTEJfSUJIUWo4cmtIdW1SWTRMbW1mWjFRbUZwdlAwYVctUFpTZEVWZlk0UVpLTGlJUU4xX29DNVcxQm52RQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T22:00:00+00:00", "published_display": "01 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Co., Ltd. (ESAIY) Analyst/Investor Day - Slideshow (OTCMKTS:ESAIY) 2026-05-25", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxONHBoWlNKQlNId3pjc215WTRILU1RcGwyYjg1UDM3QndKZzZWUHFubVdFVjhBVFJsSzNXX2o0RXhZemVhbE5RR3htbnRVRTA3dW9IdjRiRnB4N1BPb3RyZlRSOGpmczVVaEFEcUp6WkJ3b3U2cDY4MFhkSUJjYzNCN2NqRXVCZ2FENnV1T0NFQXllSjFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Valuation Check After Recent Share Price Pullback And LEQEMBI Growth Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxONkRvUkJOUnlVR0dPYzV5UTFIbmN4aEVyazZialFveXRjTTdlVTdVM1ZjRlpCMzZnaFVaVnRpRlNXeUQ1bjdlamd0bXRyajYyUW9XM3ptS2tmR0tqOHFyYUZNUmJJeUVwaDhBb0pwdGQwc1BsSk81OXhNQlpsZk5GdlhKYmNJWUd3amdrWnNMYkZZUUpWOEtBOWdIYw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai (TSE:4523) Valuation Check As Recent Momentum Meets Mixed Long Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOVUxJVkdNWk9tOHpXSjh5QjMyOS1PYkpYTFNpRDBVRGpUYWRUbmM2UXBBMEZvd0V6UW9fT1ViR0FsZ01PbG5PWFhQNExrMUFtUzFMRmVPb1RaRzNhSG4xVVNfMTlJX1dDWkFMbVNidFBYMWM4S04tSU1OZ3ZHaHhxbURXZDN4NWRWZ2FKSEcxMDZaTWVZYUZYWWw1OA?oc=5", "source_name": "Market source", "published_at": "2026-04-05T07:00:00+00:00", "published_display": "05 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Eisai (TSE:4523) Valuation After Mixed Share Price Momentum And LEQEMBI Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPa2RnMHJMMWZoZGhYaEttM0pCbVl6QUJ6VVFuT1dsUVhaMkh3SFdBMFEyRl8ybmMxWGNzcEk5OV9tN29QS214cDFXRkhjMnNHczRZeTROazN6cG91QkloNEFfM0dJTFV6S0RQOGxrbERtTGUweU0zMlFDbFBsWEJBb0ZtaUdMMWs?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai strikes Japan licensing deal with Shanghai Henlius Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTjMxVFhfOU56V1pzOFFxWWd2eWIzMTNTS1BUd1A3NFJjVGpqR0dFX2JEdTJpX1BwcnNicXdlLWVPM1BRbmVRcU5TSzN5Uy1QNDRqbUw0QXRGXzIyMU9qSmFjNU5CNzB4ZzNhRHdFb3RkS2RmRDlpanM3VzFsUDRQeW52NVJwWlVQcWhELXV1OV9hdjNsX1VqbVEydmNwVjJ5N0w4MTNpNS1pUlZvNVpEU0V5blZsbkZraFFpWVpYQURXZHFXNnZ4dGU3QVZuS2dqRWc?oc=5", "source_name": "Reuters", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai Submits New Drug Application for Subcutaneous Formulation of \u201cLEQEMBI\u00ae\u201d for the Treatment of Early Alzheimer\u2019s Disease in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQRm5BcDdYVkhlN2ZycmMwdjBuVmJfb19ma3FLY2VFNnZ5dHo5Z1dJYzU2UkE5WTlwQzA2dzJLMnhzUDhoejZoNHNMQ2hCdHg3anB3dGlIVEdtcjRsQ2Y3X1M1Wi1HV29KVmJJZTJ6YlFkN1lwUlNSdzVoZ2FtZkRkTWV2RW1qY0E2c2doRHBJSGRTY1JockstYWRkVEpOa3RsZ0hpMEFpODdmc21hOEhXalBnMzZuQXlxQWFIaTlWNzI?oc=5", "source_name": "Biogen", "published_at": "2025-11-27T08:00:00+00:00", "published_display": "27 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Eisai Co., Ltd. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIZ3pxT1hjUXJHU0lWTDJNVEM2YktqYWpLNm1OdC1WVUYtNGhQZW5OVTRyYjJ4THZVQ1NnRnpLaXBTb1dfeGlVdnN4cmJXSzdlazkyQTJDOTRKdG9Fb3lR?oc=5", "source_name": "TradingView", "published_at": "2025-09-25T03:10:06+00:00", "published_display": "25 Sep 2025 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai to Launch \u201cPariet\u00ae S,\u201d the First Proton Pump Inhibitor RX-to-OTC in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1jX1VSZlpuUzA1T25EeFJ1bzBFQWNyUTRmcHVrOXl5NGRNVzYxMjZaYkZlcERHcVNHS1R2ejRXbE95V2VDdWRDdWlEZXZyZm9MTXFnUGpMTXl0dXc?oc=5", "source_name": "Eisai", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "To Develop Japan\u2019s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research | News ReleaseNews Release\uff1a2022", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9ib2QtUlRnNEdXN1JvZnhkczhGQW9ZWnZ1WW9QODlYbnJsaVhTaGpjQnQ1UmFwaDl2d1VaaVZCSGJ4VlpwVmJGQWoyRUhVdlF4cW1BcG5VVF9JMTg?oc=5", "source_name": "Eisai", "published_at": "2022-11-22T08:00:00+00:00", "published_display": "22 Nov 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Eisai amend collaboration agreements on Alzheimer\u2019s disease treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNjhMczY5QzJjUm40c2M4aGJKRXdJbmJ5MXJPSGgtYUhpVjJvcWNwWWhQTFlmZ240ZUdUdHNIaERaSjJFNG05UmJueGVsXzhYOHNWSTZLNmhDd2dOdEdGUFd5czRwUlo3dngyaUYyM0NsMlE3ZEFndnhCbWw2dGhyaE9FR2dySXhoZmVPLThEOGhjUF9ub3laU0xtRDRZMC16VHRVUDRLODExVTFRa2Z4QWtvR0N4NktGZl8xZ1o5Yw?oc=5", "source_name": "Biogen", "published_at": "2022-03-14T07:00:00+00:00", "published_display": "14 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EISAI COMPLETES CONSTRUCTION OF THE 5TH MANUFACTURING BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN | News ReleaseNews Release\uff1a2020", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBvUk5yUEd6a3RlZk9JRFlaeHY1aVJOeW94Qy1OUW5OU0hteTJhczFYRlFRbDRjdzVTOWhkcTZkM2RRZjFqMUY4X3J2NldhUVBnclBLQzJoODNRNVE?oc=5", "source_name": "Eisai", "published_at": "2020-12-18T08:00:00+00:00", "published_display": "18 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eisai co-establishes \u201cGlobal Health Innovative Technology Fund,\u201d Japan's first public\u2013private partnership to eliminate infectious disease in developing countries | Patients and People", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE96R0NfVkE2aXhYRl9SRXREU2M3YU9OVVlYNndNM0xGaXZnMWtROHdUcFB3WU9wdUlBZnBzWjhkWmIzRl94eWFvR1RhbElvYkVCTU9ZMWxVYUJDVTNvOXUtZg?oc=5", "source_name": "Eisai", "published_at": "2013-07-11T07:00:00+00:00", "published_display": "11 Jul 2013 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 73, "total_relevant": 17, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 15, "score": 52, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "deals", "label": "Deals and strategy", "weight": 1.45, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 4296.0, "latest_week": "2026-07-10", "one_week_move": 1.0, "four_week_move": 13.7, "twelve_week_move": -12.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.687544, "market_dynamics_buy_signal": false, "relative_strength": -28.04401, "fair_value_gap": -18.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.1116, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.0% over one week, +13.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Eisai", "count": 4}, {"label": "Market source", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "Biogen", "count": 2}, {"label": "MSN", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Seeking Alpha", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.0% over one week, +13.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "How Investors May Respond To Eisai (TSE:4523) Advancing Lecanemab Data And New CNS Oncology Filings"}], "updated_at": "2026-07-17T04:23:47.390340+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}